James T. Rosenbaum, MD

Dr. Rosenbaum, professor, Medicine and Ophthalmology, Joint Professor, Cell and Developmental Biology, Casey Eye Institute, Oregon Health & Science University, Portland.

Articles

Biologic agents treat ocular inflammatory disease

Editor's Note: As defined by the FDA, the term "biologics" refers to a wide range of products that includes vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins, such as monoclonal antibodies and antibody fragments.